Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 636 | 673 | 673 | 676 | 687 | 720 | 756 | 761 | 804 | 942 | 1,003 | 1,063 |
| Expenses | 515 | 524 | 534 | 548 | 561 | 589 | 608 | 606 | 664 | 783 | 840 | 889 |
| Operating Profit | 121 | 149 | 139 | 129 | 126 | 132 | 148 | 155 | 141 | 160 | 164 | 174 |
| OPM % | 19% | 22% | 21% | 19% | 18% | 18% | 20% | 20% | 17% | 17% | 16% | 16% |
| Other Income | 12 | 13 | 26 | 22 | 21 | 38 | 26 | 22 | 20 | 19 | -10 | 29 |
| Interest | 12 | 12 | 12 | 12 | 4 | 3 | 3 | 4 | 4 | 5 | 7 | 6 |
| Depreciation | 20 | 18 | 18 | 20 | 19 | 20 | 21 | 22 | 23 | 40 | 42 | 44 |
| Profit before tax | 101 | 132 | 134 | 120 | 124 | 146 | 149 | 152 | 133 | 135 | 105 | 153 |
| Tax % | 25% | 25% | 29% | 27% | 26% | 25% | 21% | 23% | 23% | 24% | 24% | 24% |
| Net Profit | 75 | 99 | 95 | 88 | 92 | 110 | 118 | 116 | 102 | 103 | 80 | 116 |
| EPS in Rs | 3.38 | 4.45 | 4.26 | 3.67 | 3.83 | 4.58 | 4.90 | 4.85 | 4.25 | 4.28 | 3.31 | 4.82 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 553 | 643 | 966 | 1,665 | 2,306 | 2,590 | 2,839 | 3,510 | 3,813 |
| Expenses | 511 | 499 | 736 | 1,378 | 1,910 | 2,084 | 2,292 | 2,892 | 3,175 |
| Operating Profit | 42 | 144 | 230 | 287 | 396 | 505 | 548 | 619 | 638 |
| OPM % | 8% | 22% | 24% | 17% | 17% | 20% | 19% | 18% | 17% |
| Other Income | 7 | -102 | -3 | -21 | 58 | 79 | 94 | 52 | 59 |
| Interest | 6 | 9 | 7 | 6 | 31 | 49 | 22 | 19 | 22 |
| Depreciation | 17 | 19 | 26 | 33 | 60 | 76 | 80 | 126 | 149 |
| Profit before tax | 26 | 14 | 195 | 226 | 363 | 459 | 539 | 525 | 526 |
| Tax % | 45% | 191% | 23% | 28% | 27% | 27% | 25% | 24% | |
| Net Profit | 14 | -12 | 149 | 163 | 266 | 337 | 407 | 401 | 401 |
| EPS in Rs | 89.98 | -40.20 | 951.96 | 937.73 | 11.99 | 15.14 | 16.95 | 16.65 | 16.66 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 12% | 13% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 29% | 15% | 30% | ||
| Compounded Profit Growth | % | 23% | 16% | -4% | ||
| Stock Price CAGR | % | % | % | 8% | ||
| Return on Equity | % | 21% | 19% | 14% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.31 | 0.31 | 0.31 | 0.35 | 44 | 44 | 48 | 48 |
| Reserves | 73 | -105 | 324 | 764 | 1,020 | 1,385 | 2,568 | 3,091 |
| Borrowings | 147 | 483 | 51 | 66 | 502 | 490 | 102 | 144 |
| Other Liabilities | 108 | 222 | 220 | 524 | 638 | 627 | 609 | 1,337 |
| Total Liabilities | 329 | 600 | 596 | 1,353 | 2,204 | 2,546 | 3,326 | 4,620 |
| Fixed Assets | 104 | 119 | 86 | 138 | 664 | 646 | 678 | 1,812 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 12 |
| Investments | 0 | 13 | 0 | 120 | 614 | 796 | 1,290 | 1,100 |
| Other Assets | 225 | 468 | 510 | 1,096 | 926 | 1,103 | 1,355 | 1,697 |
| Total Assets | 329 | 600 | 596 | 1,353 | 2,204 | 2,546 | 3,326 | 4,620 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 65 | 22 | 172 | 297 | 130 | 508 | 442 | 651 |
| Cash from Investing Activity | -18 | -16 | -81 | -158 | -896 | -326 | -677 | -508 |
| Cash from Financing Activity | -21 | 136 | -132 | 233 | 333 | -66 | 288 | -83 |
| Net Cash Flow | 25 | 143 | -40 | 373 | -433 | 115 | 52 | 60 |
| Free Cash Flow | 48 | 16 | 151 | 272 | 111 | 497 | 412 | 606 |
| CFO/OP | 196% | 34% | 96% | 128% | 60% | 125% | 110% | 129% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60 | 127 | 108 | 97 | 102 | 91 | 97 | 102 |
| Inventory Days | ||||||||
| Days Payable | ||||||||
| Cash Conversion Cycle | 60 | 127 | 108 | 97 | 102 | 91 | 97 | 102 |
| Working Capital Days | -7 | -5 | 45 | 11 | 41 | 27 | 39 | 5 |
| ROCE % | 37% | 55% | 46% | 33% | 29% | 25% | 19% |
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| FIIs | 3.79% | 4.82% | 5.03% | 5.24% | 10.04% | 11.30% | 11.48% | 10.27% | 9.92% |
| DIIs | 3.84% | 3.17% | 3.99% | 4.96% | 7.20% | 6.95% | 8.06% | 8.29% | 8.74% |
| Public | 92.38% | 92.01% | 91.01% | 89.80% | 82.75% | 81.74% | 80.44% | 81.43% | 81.34% |
| No. of Shareholders | 2,03,599 | 1,51,440 | 1,53,789 | 1,44,708 | 1,51,997 | 1,51,809 | 1,47,182 | 1,42,119 | 1,38,533 |
Fundamentals
Market Cap₹ 14,580 Cr.
Current Price₹ 605
Stock P/E35.0
Book Value₹ 130
ROCE18.8 %
ROE14.4 %
Dividend Yield0.37 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)30%
Compounded Profit Growth (TTM)-4%
Consolidated figures.
Valuation
Market capRs 13,179 Cr
Enterprise valueRs 13,478 Cr
P/E (TTM)32.87x
Price to book9.22x
Price to sales3.46x
EV / EBITDA19.35x
EV / EBIT24.61x
EV / sales3.53x
Price to cash flow25.96x
Earnings yield3.04%
Profitability
Operating margin (excl. other income)19.52%
Operating margin (incl. other income)22.56%
EBITDA margin18.27%
Pre-tax margin13.79%
Net profit margin10.51%
Net margin, latest quarter10.93%
ROE27.01%
ROCE29.15%
ROA14.18%
ROE, 3-year average28.80%
ROCE, 3-year average33.54%
ROA, 3-year average15.35%
ROE, 5-year average52.60%
ROCE, 5-year average32.35%
ROA, 5-year average13.93%
ROIC (approx.)23.27%
Tax rate26.58%
Other income / net worth5.51%
Growth
Sales growth (latest year)12.29%
Profit growth (latest year)26.53%
Sales CAGR, 3 years38.90%
Sales CAGR, 5 years36.16%
Profit CAGR, 3 years31.11%
Profit CAGR, 5 years88.65%
Sales growth QoQ5.95%
Profit growth QoQ45.80%
Sales growth YoY (latest quarter)39.73%
Profit growth YoY (latest quarter)-0.17%
Per share
EPS (TTM)Rs 18.05
EPS (latest year)Rs 15.16
EPS (latest quarter)Rs 5.23
EPS, 3-year averageRs 322.16
EPS, 5-year averageRs 375.95
Book value per shareRs 64.36
Sales per shareRs 171.70
Cash flow per shareRs 22.86
Free cash flow per shareRs 27.29
Efficiency
Asset turnover1.02x
Fixed asset turnover4.01x
Debtor days91 days
Debtors turnover4.00x
Cash conversion cycle102 days
Working capital days5 days
Leverage
Total debtRs 490 Cr
Cash and bankRs 191 Cr
Net debtRs 299 Cr
Debt to equity0.34x
Net debt / EBITDA0.43x
Interest coverage24.89x
Current ratio (filing 2026-03-31)2.41x
Quick ratio (filing 2026-03-31)2.41x
Trade payables (filing 2026-03-31)Rs 181 Cr
Owners' fund to total sources56.14%
Debt to assets19.23%
Cash flow
Cash from Operating Activity (latest year)Rs 508 Cr
Cash from Investing Activity (latest year)Rs -326 Cr
Cash from Financing Activity (latest year)Rs -66 Cr
Net Cash Flow (latest year)Rs 115 Cr
Free cash flow (latest year)Rs 606 Cr
FCFE (approx.: FCF + change in debt)Rs 593 Cr
Cash from ops / profit, 5 years1.29x
Sales to cash flow5.10x
Statement figures
Net sales (TTM)Rs 3,813 Cr
Net sales (latest year)Rs 2,590 Cr
Sales (latest quarter)Rs 1,063 Cr
Operating profit excl. other income (latest year)Rs 505 Cr
Operating profit (latest quarter)Rs 174 Cr
Other income (TTM)Rs 59 Cr
EBITDA (TTM)Rs 696 Cr
PBDT (TTM)Rs 674 Cr
Profit before tax (TTM)Rs 526 Cr
Tax (latest year)Rs 122 Cr
Net profit (TTM)Rs 401 Cr
Net profit (latest year)Rs 337 Cr
Net profit (latest quarter)Rs 116 Cr
Depreciation (TTM)Rs 149 Cr
Depreciation (latest quarter)Rs 44 Cr
Interest (TTM)Rs 22 Cr
Cost of goods sold (latest year)Rs 235 Cr
Total expenditure (latest year)Rs 2,084 Cr
Total income (latest year)Rs 2,668 Cr
Share capitalRs 44 Cr
ReservesRs 1,385 Cr
Shareholders' fundsRs 1,429 Cr
Total assetsRs 2,546 Cr
Net blockRs 646 Cr
InvestmentsRs 796 Cr
ReceivablesRs 648 Cr
Other liabilitiesRs 627 Cr
Shares outstanding (crore)22.21
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 32.9 is at the 60th percentile of its own 2.5-year range
(median 31.4, low 22.0, high 93.3).
P/B 9.22 is at the 13th percentile (median 11.33).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | INDGN | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -0.1% | -2.8% | +2.7 pts |
| 1 month | -2.0% | -6.8% | +4.8 pts |
| 3 months | +16.8% | -7.6% | +24.4 pts |
| 6 months | +36.6% | +0.4% | +36.2 pts |
| 1 year | +3.8% | -9.9% | +13.7 pts |
| 2 years | -14.0% | -13.6% | -0.4 pts |
67 mutual fund schemes hold about ₹1,903 Cr.
Over three months 19 bought more and 13 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| Quant Small Cap Fund | 1.47% | 521 | +100% |
| ICICI Pru Healthcare Fund- | 1.92% | 134 | +100% |
| ICICI Pru Technology Fund | 0.83% | 114 | -8% |
| ICICI Pru Small Cap Fund | 1.16% | 114 | +85% |
| ICICI Pru Small Cap Fund | 1.16% | 111 | +85% |
| Sundaram Mid Cap Fund | 0.65% | 96 | -6% |
| Sundaram Mid Cap Fund | 0.65% | 94 | -6% |
| SBI Innovative Opportunities Fund | 1.67% | 87 | -33% |
| ICICI Pru Innovation Fund | 1.09% | 86 | +100% |
| Sundaram Aggressive Hybrid Fund(M | 0.68% | 63 | +3% |
| Helios Flexi Cap Fund | 0.63% | 55 | -14% |
| SBI Technology Opp Fund | 1.22% | 55 | -11% |
| Sundaram Business Cycle Fund | 2.81% | 49 | -6% |
| UTI Small Cap Fund | 0.54% | 28 | +100% |
| ICICI Pru Retirement Fund-Hybrid Aggressive Plan | 2.09% | 27 | +100% |
| Sundaram Flexi Cap Fund | 1.26% | 25 | +1% |
| ICICI Pru Quality Fund | 1.03% | 22 | +100% |
| Sundaram Multi Asset Allocation Fund | 0.64% | 22 | -0% |
| Groww Small Cap Fund | 2.48% | 19 | +100% |
| Sundaram ELSS Tax Saver Fund | 1.28% | 16 | -1% |
| Nippon India Retirement Fund-Wealth Creation | 0.49% | 15 | +100% |
| ICICI Pru Children's Fund | 1.06% | 15 | +100% |
| Helios Small Cap Fund | 1.01% | 15 | +19% |
| Helios Mid Cap Fund | 0.65% | 15 | -20% |
| Groww Multicap Fund | 0.90% | 13 | +100% |
Red flags
F-score 7 of 8| explain | Share dilution Share count up 0% in a year, 13800% in three |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹1,063 Cr +39.7% vs Jun 2025.
Net profit ₹116 Cr +0.0%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Syngene International Ltd | 14,823 | 50.0 | 9.99 % |
| Suven Life Sciences Ltd | 9,176 | -79.5 % | |
| Vimta Labs Ltd | 2,642 | 32.7 | 25.2 % |
| Fabtech Technologies Ltd | 661 | 13.6 | 13.6 % |
| Bilcare Ltd | 229 | 11.5 | 7.06 % |
| Take Ltd | 208 | 35.2 | 18.5 % |
| Novelix Pharmaceuticals Ltd | 199 | 55.1 | 10.9 % |
| Jeevan Scientific Technology Ltd | 163 | 46.7 | 5.01 % |
| Adeshwar Meditex Ltd | 24 | 19.4 | 5.21 % |
| Vanta Bioscience Ltd | 15 | 133 | 1.19 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2026-07-31 | Dividend - Rs 2.25 Per Share | |
| 2025-06-13 | Dividend - Rs 2 Per Share | |
| 2024-08-29 | Annual General Meeting |
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Indegene Ltd?
Indegene Ltd (INDGN) has a market capitalisation of Rs 14,580 Cr. at the 2026-10-01 close.
What is the P/E ratio of Indegene Ltd?
Indegene Ltd trades at a P/E of 35.0 on trailing twelve-month profit, at the 2026-10-01 close.
What were Indegene Ltd's latest quarterly results?
In the Jun 2026 quarter, Indegene Ltd sales was Rs 1,063 Cr (+39.7% vs Jun 2025) and net profit was Rs 116 Cr.
What is the 52-week high and low of Indegene Ltd?
The 52-week high is Rs 627.00 and the 52-week low is Rs 414.00.